5 completed, 1 withdrawn. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Withdrawn 1 |
Follow casopitant: new trials by email Literature Review of casopitant trials Research Report on casopitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy Dexamethasone, IV casopitant (placebo), IV casopitant (active) - Cancer, Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Withdrawn | GlaxoSmithKline | 2009-09-01 | 2015-04-17 | |
| A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. Casopitant, Dexamethasone, Placebo - Nausea and Vomiting, Chemotherapy-Induced | Phase 3 | Completed | GlaxoSmithKline | 710 | 2008-03-10 | 2018-01-17 |
| A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy Oral Casopitant (GW679769), IV Casopitant (GW679769), IV ondansetron hydrochloride - Nausea and Vomiting, Chemotherapy-Induced | Phase 3 | Completed | GlaxoSmithKline | 810 | 2006-11-06 | 2017-08-22 |
| Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting Casopitant (GW679769) oral tablets, Casopitant (GW679769) intravenous, Dexamethasone intravenous - Vomiting, Nausea | Phase 3 | Completed | GlaxoSmithKline | 1840 | 2006-07-01 | 2012-09-10 |
| Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women GW679769 (casopitant) - Nausea and Vomiting, Postoperative | Phase 3 | Completed | GlaxoSmithKline | 482 | 2006-03-01 | 2016-10-26 |
| Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women casopitant - Nausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting | Phase 3 | Completed | GlaxoSmithKline | 515 | 2006-03-01 | 2017-03-23 |
Nausea (4) · Vomiting (4) · Postoperative Nausea and Vomiting (2) · Colorectal Neoplasms (1) · Lung Neoplasms (1) · Neoplasms (1)
GlaxoSmithKline (6)
Canada (5) · United States (5) · Belgium (4) · Czechia (4) · Germany (4) · Hungary (4) · Pakistan (4) · Philippines (4) · Thailand (4) · Bulgaria (3) · Hong Kong (3) · Ireland (3) · Italy (3) · Russia (3) · Slovakia (3)